Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 44
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Master Protocol to Compare MTX/5-FU vs CACP/5-FU vs Phase II Agent for Squamous Cell Cancer of the Head and Neck (Summary last modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
no age specified
NCI
SWOG-8223/24/25
SWOG-8224, SWOG-8225
2.
Phase II/III Chemotherapy with ADR vs DHAD vs ADC for Breast Cancer Not Previously Exposed to Intercalating Agents
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
no age specified
NCI
SWOG-8203/04
SWOG-8204
3.
Phase III Single-Agent Chemotherapy with Best Drug Selected by Clinician vs Best Selected by Capillary Cloning System for Disseminated, Refractory Breast, Ovarian, non-Small Cell and Small Cell Lung, Colon, and Renal Cancer and Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
UTHSC-82305155
NCI-T85-0023W, T85-0023
4.
Phase I-II Chemotherapy with ADC for Refractory Adult Acute Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
over 15
UMCC-8103
Last Modified:
10/26/2007
5.
Phase I/II Mitoxantrone by Hepatic Arterial Infusion for Primary or Metastatic Hepatic Tumor Refractory to All Known Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
over 18
UTHSC-82305005
CTEPIS-0146, NCI-W83-0089, W83-0089
6.
Phase II Single-Agent Master Protocol for Advanced, Unresectable non-Small Cell Bronchogenic Carcinoma --- ADC (CL 216,942)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D81-012-538
ICC-81L1
7.
Master Protocol for Phase II Chemotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck --- ADC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D82-070-646
WRAMC-8205
8.
Phase II Chemotherapy with ADC on a Single-Dose Schedule for Advanced Renal Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
UMCC-8031
9.
Phase II Chemotherapy with CL 216,942 in Women with Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
UTHSC-BR-1
10.
Master Protocol for Phase II Chemotherapy for Advanced or Metastatic non-Small Cell Lung Carcinoma --- ADC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 16
NCI
CLB-8141
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute